DLGAP5在低氧性肺动脉高压中的表达和潜在临床价值
DOI:
作者:
作者单位:

1.武汉科技大学附属天佑医院心胸外科;2.华中科技大学同济医学院附属同济医院心脏大血管外科;3.华中科技大学同济医学院附属协和医院心脏大血管外科

作者简介:

通讯作者:

中图分类号:

基金项目:


Expression of DLGAP5 in hypoxic pulmonary hypertension and its potential clinical value
Author:
Affiliation:

1.Department of Cardiothoracic Surgery,Tianyou Hospital,Wuhan University of Science and Technology;2.Division of Cardiovascular Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology;3.Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology;4.Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探究Discs大同源物相关蛋白5(DLGAP5)在低氧性肺动脉高压(HPH)中的表达变化及其潜在临床价值。方法 本研究首先使用生物信息学分析探索DLGAP5在正常对照组和HPH组中的表达情况。然后收集9例HPH行肺移植手术患者和4例对照组的肺组织样本,通过蛋白质免疫印迹实验(WB)验证DLGAP5在不同肺组织的表达水平。构建Sugen5416联合慢性缺氧(SuHx)动物模型,检测肺动脉平均压(mPAP),并应用苏木素-伊红(HE)染色、免疫组织化学(IHC)染色和免疫荧光(IF)染色等方法检测模型下肺血管重塑情况以及DLGAP5在HPH中的表达。最后采用差异基因富集分析探索DLGAP5调控HPH的下游信号通路。结果 DLGAP5在HPH患者肺组织中表达显著上调(P<0.05)。SuHx诱导的HPH模型大鼠mPAP明显升高(P<0.05)。HE染色和IHC染色结果表明,HPH模型大鼠的肺动脉中膜增厚,发生了明显的血管重塑。IF染色结果显示,相比对照组,DLGAP5在HPH模型大鼠肺动脉中膜平滑肌中表达增加(P<0.05),且主要分布在细胞质中。差异基因富集分析包括GO和GSEA分析表明DLGAP5可能通过影响细胞周期,特别是G2/M期来实现对HPH的调控(P<0.05)。 结论 DLGAP5可能作为HPH的潜在新靶点,为肺动脉高压的诊断和治疗带来新的思路。

    Abstract:

    Objective To explore the expression of disc large homology-associated protein 5 (DLGAP5) in the hypoxic pulmonary hypertension(HPH). Methods This study first used bioinformatics analysis to explore the expression of DLGAP5 in normal control group and HPH group. Then, lung tissue samples from 9 patients undergoing lung transplantation with HPH and 4 controls were collected, and the expression level of DLGAP5 in different lung tissues was detected by Western blot (WB). Rat models of Sugen5416 combined with chronic hypoxia(SuHx) was constructed to detect the mean pulmonary artery pressure(mPAP). The pulmonary vascular remodeling and the expression of DLGAP5 in HPH were detected by hematoxylin-eosin (HE) staining, immunohistochemistry (IHC) staining and immunofluorescence (IF) staining. Finally, differential gene enrichment analysis was used to explore the downstream signaling pathway of DLGAP5 regulating HPH. Results DLGAP5 was significantly upregulated in the lung tissue of HPH patients (P<0.05). The mPAP of SuHx-induced HPH model rats was significantly increased (P<0.05). The results of HE staining and IHC staining showed that the pulmonary artery media was thickened and obvious vascular remodeling occurred in the HPH model rats. The results of IF staining showed that compared with the control group, the expression of DLGAP5 in pulmonary artery media smooth muscle in HPH rats was increased (P<0.05), and it was mainly distributed in the cytoplasm. Finally, differential gene enrichment analysis, including GO and GSEA analysis, suggested that DLGAP5 may regulate HPH by influencing the cell cycle, especially the G2/M phase (P<0.05). Conclusions DLGAP5 may be a potential new target for HPH, bringing new ideas for the diagnosis and treatment of pulmonary hypertension.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-07-22
  • 最后修改日期:2025-08-09
  • 录用日期:2025-12-30
  • 在线发布日期:
  • 出版日期: